9896
L. S. Jeong et al. / Bioorg. Med. Chem. 16 (2008) 9891–9897
a
-Isomer (17a): UV kmax (MeOH) 254.0 nm; 1H NMR (CDCl3) d
4.1.14. b-D-2’,3’-Dideoxy-4’-selenothymidine (3)
8.03–8.06 (m, 2H), 7.90–7.93 (m, 2H), 7.57–7.67 (m, 3H), 7.44–
7.51 (m, 4H), 6.63 (t, 1H, J 6.8), 4.57–4.63 (m, 1H), 4.32–4.42 (m,
2H), 2.58–2.66 (m, 1H), 2.39–2.46 (m, 1H), 2.05–2.19 (m, 1H),
1.99 (s, 3H); 13C NMR (CDCl3) d 169.0, 166.3, 162.8, 149.7, 137.2,
The mixture of 17 (0.43 g, 0.86 mmol) in methanolic ammonia
(5 mL) was stirred at room temperature overnight. The solvent
was evaporated and the residue was purified by silica gel column
chromatography (CH2Cl2/MeOH = 30:1) to give 3 (0.22 g, 88%) as a
white solid: mp 144.7–147.9 °C (from MeOH/ether); UV kmax
(MeOH) 271.5 nm; 1H NMR (CD3OD) d 7.94 (s, 1H), 6.43 (t, 1H, J
6.8), 3.84–3.93 (m, 2H), 3.77 (dd, 1H, J 5.2 and 10.4), 2.31–2.36 (m,
2H), 2.13–2.20 (m, 2H), 1.90 (s, 3H); 13C NMR (CD3OD) d 166.4,
135.3, 133.5, 131.7, 130.7, 129.9, 129.4, 128.7, 111.8, 67.9, 58.2,
23
45.0, 38.7, 33.8, 13.0; m/z (FAB) 497 (M+); [
a
]
75.77 (c 10.51
D
in CH2Cl2); Calcd for C24H22N2O5Se: C, 57.95; H, 4.46; N, 5.63.
Found: C, 57.76; H, 4.06; N, 5.44.
152.7, 139.8, 111.7, 66.6, 59.2, 50.5, 38.4, 33.7, 12.6; m/z (FAB) 289
25
4.1.11. b-
benzoyluridine (18) and its
Compound 16 (0.23 g, 0.84 mmol) was converted to b-isomer
18 (174.6 mg, 43%) as a white foam and -isomer 18a (199.0 mg,
D
-5’-Benzoyl-2’,3’-dideoxy-4’-seleno-N3-
-isomer (18a)
(M+); [
a
]
D ꢀ120.16 (c 0.13 in MeOH); Calcd for C10H14N2O3Se: C,
a
41.53; H, 4.88; N, 9.69. Found: C, 41.87; H, 4.98; N, 10.08.
a
4.1.15. -2’,3’-Dideoxy-4’-selenothymidine (3a)
a-D
49%) as a white foam according to the similar procedure used in
Compound 17a (0.58 g, 1.17 mmol) was converted to 3a
(0.30 g, 90%) as a white solid according to the similar procedure
used in the preparation of 3: mp 208.7–210.3 °C (from MeOH/
ether); UV kmax (MeOH) 271.0 nm; 1H NMR (CD3OD) d 7.81 (s,
1H), 6.48 (t, 1H, J 6.8), 4.10–4.17 (m, 1H), 3.80 (dd, 1H, J 6.8
and 11.2), 3.61 (dd, 1H, J 7.6 and 11.6), 2.42–2.50 (m, 1H),
2.31–2.39 (m, 1H), 2.17–2.26 (m, 1H), 1.85–1.94 (m, 4H); 13C
the preparation of 17 and 17a.
b-Isomer (18): UV kmax (MeOH) 253.5 nm; 1H NMR (CDCl3) d
8.04–8.07 (m, 2H), 8.00 (d, 1H, J 8.4), 7.91–7.93 (m, 2H), 7.58–
7.66 (m, 2H), 7.45–7.51 (m, 4H), 6.53 (t, 1H, J 6.4), 5.80 (d,
1H, J 8.0), 4.73 (dd, 1H, J 7.2 and 11.6), 4.57 (dd, 1H, J 6.4 and
11.6), 4.08–4.13 (m, 1H), 2.43–2.50 (m, 1H), 2.26–2.33 (m, 2H),
2.12–2.19 (m, 1H); 13C NMR (CDCl3)
d
171.6, 168.8, 166.4,
NMR (CD3OD) d 139.6, 112.1, 67.4, 58.2, 50.6, 38.7, 34.4, 12.6;
25
162.1, 149.7, 141.7, 135.4, 133.8, 133.7, 131.5, 130.7, 130.3,
m/z (FAB) 289 (M+); [
a
]
230.43 (c 0.09 in MeOH); Calcd for
D
129.8, 129.7, 129.4, 128.8, 128.6, 102.7, 67.0, 59.3, 45.2, 38.2,
C10H14N2O3Se: C, 41.53; H, 4.88; N, 9.69. Found: C, 41.93; H,
4.49; N, 9.99.
24
32.9; m/z (FAB) 483 (M+); [
a]
ꢀ3.71 (c 5.42 in CH2Cl2); Calcd
D
for C23H20N2O5Se: C, 57.15; H, 4.17; N, 5.80. Found: C, 57.43; H,
4.56; N, 5.40.
4.1.16. b-
D-2’,3’-Dideoxy-4’-selenouridine (4)
a
-Isomer (18a): UV kmax (MeOH) 253.5 nm; 1H NMR (CDCl3) d
Compound 18 (0.38 g, 0.79 mmol) was converted to
4
8.02–8.05 (m, 2H), 7.91–7.94 (m, 2H), 7.63–7.67 (m, 1H), 7.56–
7.61 (m, 1H), 7.44–7.52 (m, 4H), 6.59 (t, 1H, J 6.4), 5.92 (d, 1H, J
8.4), 4.58 (dd, 1H, J 6.8 and 10.8), 4.32–4.39 (m, 2H), 2.58–2.64
(m, 1H), 2.35–2.39 (m, 1H), 2.05–2.19 (m, 2H); 13C NMR (CDCl3)
d 168.8, 166.2, 162.1, 149.6, 141.6, 135.4, 133.5, 131.5, 130.7,
(0.19 g, 90%) as a white solid according to the similar procedure
used in the preparation of 3: mp 163.5–166.4 °C (from MeOH/
ether); UV kmax (MeOH) 267.0 nm; 1H NMR (CD3OD) d 8.13
(d, 1H, J 8.0), 6.42 (t, 1H, J 6.0), 5.74 (d, 1H, J 8.0), 3.84–3.93
(m, 2H), 3.76 (dd, 1H, J 6.0 and 10.4), 2.31–2.37 (m, 2H),
2.19–2.24 (m, 1H), 2.08–2.11 (m, 1H); 13C NMR (CD3OD) d
129.9, 129.8, 129.4, 128.7, 102.9, 67.7, 58.6, 44.9, 38.7, 33.6; m/z
24
(FAB) 483 (M+);
[
a]
89.14 (c 3.61 in CH2Cl2); Calcd for
D
166.3, 152.6, 144.3, 102.8, 66.7, 59.4, 50.6, 38.5, 33.7; m/z
25
(FAB) 276 (M+H+); [
a
]
ꢀ176.04 (c 0.10 in MeOH); Calcd for
C23H20N2O5Se: C, 57.15; H, 4.17; N, 5.80. Found: C, 56.96; H,
4.54; N, 5.54.
D
C9H12N2O3Se: C, 39.28; H, 4.40; N, 10.18. Found: C, 39.54; H,
4.67; N, 9.98.
4.1.12. b-D-2’,3’-Dideoxy-4’-selenocytidine (2)
To a stirred solution of b-isomer 12 (0.46 g, 0.74 mmol) in THF
(46 mL), TBAF (1.11 mL, 1 M solution in THF, 1.11 mmol) was
added and the mixture was stirred at room temperature for 0.5 h
and evaporated. To this residue, methanolic ammonia (5 mL) was
added and the reaction mixture was stirred at room temperature
overnight. The solvent was evaporated and the residue was puri-
fied by silica gel column chromatography (CH2Cl2:MeOH = 30:1)
to give 2 (0.17 g, 84%) as a white solid: mp 139.3–147.4 °C (from
MeOH/ether); UV kmax (MeOH) 277.0 nm; 1H NMR (CD3OD) d
8.14 (d, 1H, J 7.6), 6.45 (t, 1H, J 5.6), 5.93 (d, 1H, J 7.6), 3.82–3.92
(m, 2H), 3.75 (dd, 1H, J 6.0 and 10.4), 2.29–2.38 (m, 2H), 2.18–
2.27 (m, 1H), 2.00–2.09 (m, 1H); 13C NMR (CD3OD) d 167.4,
4.1.17.
a-D-2’,3’-Dideoxy-4’-selenouridine (4a)
Compound 18a (0.45 g, 0.93 mmol) was converted to 4a (0.24 g,
92%) as a white solid according to the similar procedure used in the
preparation of 3: mp 187.1–188.1 °C (from MeOH/ether); UV kmax
(MeOH) 267.0 nm; 1H NMR (CD3OD) d 8.03 (d, 1H, J 8.0), 6.46 (t,
1H, J 6.8), 5.75 (d, 1H, J 8.0), 4.07–4.14 (m, 1H), 3.79 (dd, 1H, J
6.8 and 11.2), 3.60 (dd, 1H, J 7.6 and 11.2), 2.43–2.51 (m, 1H),
2.27–2.35 (m, 1H), 2.17–2.25 (m, 1H), 1.91–2.00 (m, 1H); 13C
NMR (CD3OD) d 166.2, 152.5, 144.3, 103.1, 67.3, 58.6, 50.5, 38.8,
34.2; m/z (FAB) 276 (M+H+); [
a] D 268.37 (c 0.10 in MeOH); Calcd
25
for C9H12N2O3Se: C, 39.28; H, 4.40; N, 10.18. Found: C, 39.08; H,
4.43; N, 10.09.
158.6, 144.6, 96.4, 66.8, 60.4, 50.3, 38.7, 33.7; m/z (FAB) 276
25
(M+); [
a]
-141.18 (c 0.12 in MeOH); Calcd for C9H13N3O2Se: C,
D
Acknowledgments
39.43; H, 4.78; N, 15.33. Found: C, 39.43; H, 4.67; N, 15.12.
This work was supported by Grant No. R15–2006-020 from
the National Core Research Center (NCRC) program of the Minis-
try of Education, Science and Technology (MEST) and the Korea
Science and Engineering Foundation (KOSEF) through the Center
for Cell Signalling & Drug Discovery Research at Ewha Womans
University.
4.1.13. -2’,3’-Dideoxy-4’-selenocytidine (2a)
a
-D
Compound 12a (0.48 g, 0.78 mmol) was converted to 2a (0.18 g,
83%) as a white solid according to the similar procedure used in the
preparation of 2: mp 188.0–197.4 °C (from MeOH/ether); UV kmax
(MeOH) 277.0 nm; 1H NMR (CD3OD) d 8.04 (d, 1H, J 7.6), 6.49 (t,
1H, J 6.8), 5.94 (d, 1H, J 7.6), 4.04–4.10 (m, 1H), 3.78 (dd, 1H, J
7.2 and 11.2), 3.60 (dd, 1H, J 7.2 and 10.8), 2.42–2.50 (m, 1H),
2.15–2.32 (m, 2H), 1.94–2.02 (m, 1H); 13C NMR (CD3OD) d 167.5,
Supplementary data
158.7, 144.5, 96.6, 67.3, 59.7, 50.0, 38.8, 34.1; m/z (FAB) 276
25
(M+); [
a]
342.27 (c 0.10 in MeOH); Calcd for C9H13N3O2Se: C,
Supplementary data associated with this article can be found,
D
39.43; H, 4.78; N, 15.33. Found: C, 39.65; H, 5.18; N, 14.98.